Top Markets
#1 Velvet Velvet +31.64%
#2 Prom Prom +31.47%
#3 QuantixAI QuantixAI +31.15%
#4 MowCat MowCat +28.48%
#5 Tutorial Tutorial +24.58%
#6 UnifAI Network UnifAI Network +24.16%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.99%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +20.82%
#9 MarsCoin MarsCoin +18.70%
#10 Versatize Coin Versatize Coin +16.65%
Coin of the day
Velvet Velvet
Settings
Language
ENGLISH
Currency
USD
Theme
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Rank in Stocks #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Share Price
$20.38
Market Cap
$129.09M
Change (1 day)
-0.82%
Change (1 year)
80.91%
Country
PL
Trade Captor Therapeutics Spolka Akcyjna (CTX)

Category

Healthcare
Operating Margin for Captor Therapeutics Spolka Akcyjna (CTX)
Operating Margin as of 2026 TTM: 0.00%
According to Captor Therapeutics Spolka Akcyjna latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Captor Therapeutics Spolka Akcyjna from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.